Summit Therapeutics Inc logo

SMMT

Summit Therapeutics Inc

$9.47

Earnings Summary

Net Profits
$-43.47Mn

Highlights

Net Profits:

Summit Therapeutics Inc’s net profit fell -195.39% since last year same period to $-43.47Mn in the Q2 2024. On a quarterly growth basis, Summit Therapeutics Inc has generated 0% jump in its net profits since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Summit Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.06
EPS Estimate Current Year
-0.06

Highlights

EPS Estimate Current Quarter:

Summit Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.06 - a 0% jump from last quarter’s estimates.

EPS Estimate Current Year:

Summit Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.06.

Key Ratios

Key ratios of the Summit Therapeutics Inc post its Q1 2024 earnings

Earning Per Share (EPS)
-0.06
Return on Assets (ROA)
-0.33
Return on Equity (ROE)
-1.31

Highlights

Earning Per Share (EPS):

Summit Therapeutics Inc’s earning per share (EPS) jumped 95.82% since last year same period to -0.06 in the Q1 2024. This indicates that the Summit Therapeutics Inc has generated 95.82% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Summit Therapeutics Inc’s return on assets (ROA) stands at -0.33.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Summit Therapeutics Inc’s return on equity (ROE) stands at -1.31.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-01
-0.06
-0.06
0%